Back to funds

Redmile Group, LLC

Updated 6 days ago

Managed by Redmile Group, Llc • Latest filing Q3 2026

Portfolio value
$1.4B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$1.4B
Q1 2026$1.5B
Q2 2026$1.5B
Q3 2026$1.4B

Top holdings

44 positions as of Q3 2026

View filing
N

NURIX THERAPEUTICS INC

Value
$187.3M
Shares
7.90M
% Port
13.71%
K

KRYSTAL BIOTECH INC

Value
$175.5M
Shares
527.7K
% Port
12.84%
S

SCHOLAR ROCK HLDG CORP

Value
$146.6M
Shares
3.03M
% Port
10.73%
S

STOKE THERAPEUTICS INC

Value
$100.6M
Shares
3.87M
% Port
7.36%
I

IMMUNOME INC

Value
$93.8M
Shares
4.36M
% Port
6.87%
A

ABSCI CORPORATION

Value
$71.9M
Shares
6.67M
% Port
5.26%
?
7.N/A

ELECTRA THERAPEUTICS INC

Value
$61.1M
Shares
5.43M
% Port
4.47%
A

ANNEXON INC

Value
$60.4M
Shares
14.28M
% Port
4.42%
N

NEUROGENE INC

Value
$43.5M
Shares
1.56M
% Port
3.18%
R

REGENXBIO INC

Value
$38M
Shares
5.05M
% Port
2.78%
S

SHATTUCK LABS INC

Value
$34.7M
Shares
5.09M
% Port
2.54%
F

FATE THERAPEUTICS INC

Value
$30.5M
Shares
12.87M
% Port
2.23%
S

SILENCE THERAPEUTICS PLC

Value
$26.9M
Shares
2.46M
% Port
1.97%
B

BEAM THERAPEUTICS INC

Value
$26M
Shares
1.06M
% Port
1.90%
?
15.N/A

ATTOVIA THERAPEUTICS INC

Value
$19.9M
Shares
1.16M
% Port
1.46%
A

AGOMAB THERAPEUTICS NV

Value
$19.3M
Shares
1.74M
% Port
1.41%
N

NUVATION BIO INC

Value
$17M
Shares
3.03M
% Port
1.24%
A

ADARX PHARMACEUTICALS INC

Value
$15.3M
Shares
769.3K
% Port
1.12%
I

IDEAYA BIOSCIENCES INC

Value
$14.7M
Shares
381.3K
% Port
1.07%
A

ADC THERAPEUTICS SA

Value
$14.1M
Shares
11.58M
% Port
1.03%

Explore